Results 91 to 100 of about 1,473,215 (222)
Ultraviolet A1 (UVA1) phototherapy (spectral range 340‐400 nm) is a well‐established treatment option for various skin diseases such as localized scleroderma. Recent improvements of conventional UVA1 light sources (metal‐halide or fluorescent lamps) have
S. Arndt +5 more
semanticscholar +1 more source
Clinicopathological Challenge: A Progressively Enlarging Hardened Skin Plaque
ABSTRACT Stiff skin syndrome (SSS) is a rare connective tissue disease manifesting as a progressive, non‐inflammatory fibrosis that causes the skin and soft tissues to harden. It can result in restricted joint movement, particularly affecting the shoulder and pelvic girdle. A segmental variant with a better prognosis has been described.
Marian Fernández Martínez +3 more
wiley +1 more source
Juvenile Localized Scleroderma. Questions of Treatment
Juvenile localized scleroderma (JLS) is a group of childhood diseases with the main symptom — skin and subcutaneous structures lesions, without any organ involvement. There is active (inflammatory) and fibrotic phase in development of JLS.
Rinat K. Raupov, Mikhail M. Kostik
doaj +1 more source
Objective. To perform a comparative effectiveness feasibility study in juvenile localized scleroderma (LS), using standardized treatment regimens (consensus treatment plans; CTP). Methods.
Suzanne C. Li +14 more
semanticscholar +1 more source
Localized scleroderma (morphea) is a chronic autoimmune disease of the connective tissue. Its etiopathogenesis is unknown. Most often the disease affects the skin, but may also involve the subcutis, muscles, and the osteoarticular system.
D. Krasowska +10 more
semanticscholar +1 more source
Recent Advances in Localized Scleroderma
Localized scleroderma (LSc), or morphea, is an autoimmune connective tissue disease causing inflammation and fibrosis of the skin and underlying tissues. While distinct from systemic sclerosis, its clinical presentation is highly diverse.
Toshiya Takahashi +2 more
doaj +1 more source
Objectives To assess reliability of the two indexes of Localized Scleroderma Cutaneous Assessment Tool (LoSCAT), the modified Localized Scleroderma Skin Severity Index (mLoSSI) and the Localized Scleroderma Skin Damage Index (LoSDI), when applied by ...
Anna Agazzi +4 more
doaj +1 more source
Features of the course of and diagnostics of juvenile localized scleroderma: analysis of clinical cases [PDF]
T.V. Мarushko +3 more
openalex +1 more source
MicroRNA in localized scleroderma: a review of literature
Localized scleroderma (LoSc) is rare connective tissue disease that manifests with inflammation and fibrosis of the skin. Depending on the LoSc subtype, adjacent structures such as subcutaneous tissue, fascia, muscles, bones may be affected. The hallmark
Katarzyna Wolska-Gawron +2 more
semanticscholar +1 more source
Correction to: Single-cell transcriptome conservation in a comparative analysis of fresh and cryopreserved human skin tissue: pilot in localized scleroderma [PDF]
Emily Mirizio +7 more
openalex +1 more source

